BlackRock, Inc. 13D and 13G filings for Seres Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-05 12:21 pm Sale |
2024-03-31 | 13G | Seres Therapeutics, Inc. MCRB |
BlackRock Inc. BLK |
341,270 4.500% |
-25,703 (-7.00%) |
Filing |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
BlackRock Inc. BLK |
366,973 5.700% |
54,518 (+17.45%) |
Filing |
| 2023-04-06 09:29 am Sale |
2023-03-31 | 13G | Seres Therapeutics, Inc. MCRB |
BlackRock Inc. BLK |
312,454 5.000% |
-10,494 (-3.25%) |
Filing |
| 2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
BlackRock Inc. BLK |
322,949 5.200% |
29,231 (+9.95%) |
Filing |
| 2022-08-09 4:02 pm Purchase |
2022-07-31 | 13G | Seres Therapeutics, Inc. MCRB |
BlackRock Inc. BLK |
293,718 4.700% |
583 (+0.20%) |
Filing |
| 2022-02-03 4:41 pm Sale |
2021-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
BlackRock Inc. BLK |
293,135 6.400% |
-20,557 (-6.55%) |
Filing |
| 2021-02-01 08:30 am Purchase |
2020-12-31 | 13G | Seres Therapeutics, Inc. MCRB |
BlackRock Inc. BLK |
313,692 6.900% |
113,524 (+56.71%) |
Filing |